U.S. RESEARCH ROUNDUP-Expedia Group, Meta Platforms, Rayzebio

Iovance Biotherapeutics

27/12/2023 14:49

Dec 27 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Expedia Group, Meta Platforms and Rayzebio,
on Wednesday. 
    
      HIGHLIGHTS        
                 * Booking Holdings Inc  BKNG.O : Wedbush raises target price to $3,850 from $3,300
 
                 * Expedia Group Inc  EXPE.O : Wedbush raises target price to $130 from $115
 
                 * Meta Platforms Inc  META.O : Wedbush raises target price to $420 from $350 
 
                 * Pinterest Inc  PINS.N : Wedbush raises target price to $35 from $32 
 
                 * Rayzebio Inc  RYZB.O : William Blair cuts to market perform 
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.   

                 * Booking Holdings Inc  BKNG.O : Wedbush raises target price to $3,850 from $3,300
 
                 * Expedia Group Inc  EXPE.O : BTIG raises target price to $175 from $150
 
                 * Expedia Group Inc  EXPE.O : Wedbush raises target price to $130 from $115
 
                 * Global Partners LP  GLP.N : Stifel raises target price to $44 from $40
 
                 * Humacyte Inc  HUMA.O : Benchmark cuts target price to $15 from $16
 
                 * Iovance Biotherapeutics Inc  IOVA.O : H.C. Wainwright cuts PT to $28 from $38
 
                 * Lyft Inc  LYFT.O : Wedbush raises target price to $14 from $12 
 
                 * Maplebear Inc  CART.O : Wedbush cuts target price to $26 from $30 
 
                 * Meta Platforms Inc  META.O : Wedbush raises target price to $420 from $350 
 
                 * Organogenesis Holdings Inc  ORGO.O : BTIG raises target price to $6 from $4 
 
                 * Pinterest Inc  PINS.N : Wedbush raises target price to $35 from $32 
 
                 * Rayzebio Inc  RYZB.O : William Blair cuts to market perform 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))